References
-
1) Autophagy enhanced antitumor effect in K562 and K562/ADM cells using realgar transforming solution.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: BIOMED PHARMACOTHERImpactFactor: 6.9DOI: 10.1016/j.biopha.2017.12.038PMID: 29272786 -
2) MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: BIOCHEM BIOPH RES COImpactFactor: 2.5DOI: 10.1016/j.bbrc.2018.03.007PMID: 29526753 -
3) Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: EXP CELL RESImpactFactor: 3.3DOI: 10.1016/j.yexcr.2018.05.003PMID: 29746817 -
4) Diffusion Tensor Imaging Evaluation of Axonal/White Matter Remodeling in a Mouse Model of Diabetic Stroke Treated with Novel p38 MAPK Inhibitor, VCP979.
Product: beta Actin Antibody (#AF7018)Year: 2018Journal: J BIOMED NANOTECHNOLImpactFactor: 2.9DOI: 10.1166/jbn.2018.2522PMID: 29663930 -
5) Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: BIOMED RES INTImpactFactor: 2.6DOI: 10.1155/2017/4391920PMID: 28116308 -
6) miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: CELL PROLIFERATImpactFactor: 5.9DOI: 10.1111/cpr.12341PMID: 28217977 -
7) Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2017.00042PMID: 28217099 -
8) CUL4A promotes cell invasion in gastric cancer by activating the NF-κB signaling pathway.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: BIOL-TARGETS THERImpactFactor: 5.3DOI: 10.2147/BTT.S127650PMID: 28442889 -
9) Tcf12, A Member of Basic Helix-Loop-Helix Transcription Factors, Mediates Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation In Vitro and In Vivo.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: STEM CELLSImpactFactor: 4DOI: 10.1002/stem.2491PMID: 27574032 -
10) PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: J Exp Clin Cancer ResImpactFactor: 11.3DOI: 10.1186/s13046-017-0593-2PMID: 28915924 -
11) Expression and clinical relevance of SPOPL in medulloblastoma.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: ONCOL LETTImpactFactor: 2.5DOI: 10.3892/ol.2017.6500PMID: 28928843 -
12) Crocetin inhibits the proliferation, migration and TGF-β 2-induced epithelial-mesenchymal transition of retinal pigment epithelial cells .
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: EUR J PHARMACOLImpactFactor: 4.2DOI: 10.1016/j.ejphar.2017.09.041PMID: 28970011 -
13) Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: MOL MED REPImpactFactor: 3.4DOI: 10.3892/mmr.2017.6619PMID: 28560414 -
14) Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: BIOMED PHARMACOTHERImpactFactor: 6.9DOI: 10.1016/j.biopha.2017.03.046PMID: 28363167 -
15) circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.
Product: beta Actin Antibody (#AF7018)Year: 2017Journal: J EXP CLIN CANC RESImpactFactor: 11.3DOI: 10.1186/s13046-017-0614-1PMID: 29037220